Clinical Trial Update: Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). [Phase 3]

View source ↗

Summary

Phase 3 immunogenicity and safety trial evaluating combined or separate vaccines against common childhood diseases in infants (2, 4, 6 months).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Hepatitis B
• Poliomyelitis
• Tetanus

Drugs mentioned

• GlaxoSmithKline vaccine regimen

Snippet

Sponsor: GlaxoSmithKline | Conditions: Poliomyelitis, Tetanus | Phase 3 | Status: COMPLETED